14.09.2021 14:07:02
|
Mesa Labs To Acquire Agena Bioscience For $300 Mln Cash - Quick Facts
(RTTNews) - Mesa Laboratories, Inc. (MLAB) announced Tuesday that it has entered into a definitive agreement to acquire Agena Bioscience, Inc. for a cash purchase price of $300 million, subject to customary purchase price adjustments.
Mesa expects to finance the all-cash transaction with a combination of cash on hand and proceeds from its credit facility.
The transaction is expected to be completed in Mesa's third fiscal quarter ending December 31, 2021, and is subject to customary conditions, including receipt of applicable regulatory approvals.
San Diego, California-based Agena is a leading molecular diagnostics tools company that develops, manufactures, and supplies highly sensitive, low-cost, high-throughput, genetic analysis solutions to clinical labs and development partners globally.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Mesa Laboratories IncShsmehr Nachrichten
03.02.25 |
Ausblick: Mesa Laboratories legt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
21.01.25 |
Erste Schätzungen: Mesa Laboratories stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) |
Analysen zu Mesa Laboratories IncShsmehr Analysen
Aktien in diesem Artikel
Mesa Laboratories IncShs | 138,90 | 1,19% |